Phase Capital Information

Phase Capital invests in pre-seed to Series A companies at the convergence of biology, engineering, and data science. We back companies pioneering next-generation tools that convert biological complexity into technological opportunity—from life-changing therapeutics to scalable, sustainable solutions across industry and society. We partner with technical founders who view biology as technology's next frontier.